CSL LIMITED (CSL)

Health care · Historical news and closing prices

CSL Shareholders Back Board Resolutions As Leadership Changes Loom

CSL · Health care · 2026-10-27

CSL shareholders approved all four resolutions reported, including the elections of Gordon Naylor and Costa Saroukos and adoption of the remuneration report. Naylor is set to become chair next year, while incoming CEO Deborah Waterhouse is due to take up her role in February; the AGM address described the past financial year as a reset after a challenging period, but the supplied excerpt does not include the full outlook.

Closing price · 2026-10-27: $196.78 · +0.84%

CSL Names Gordon Naylor Next Chair As Brian McNamee Retires

CSL · Health care · 2026-10-26

CSL says Brian McNamee will retire from its board and Gordon Naylor will become chair, with both changes effective from March 2027. Naylor, who has served as interim CEO and managing director since February 2026, is due to continue in that role until February 2027 before returning to the board as a non-executive director and chair-elect. Carolyn Hewson will become senior independent director, as Naylor will not initially be considered an independent chair because of his recent executive role.

Closing price · 2026-10-26: $195.14 · -0.79%